{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-215541","form_type":"8-K","ticker":"IVVD","cik":"0001832038","company_name":"Invivyd, Inc.","filed_at":"2025-09-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.212858+00:00","generated_at":"2026-05-17T05:48:33.780475+00:00","sec_items":["5.02","7.01","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Invivyd appoints Paul B. Bolno, M.D. to board; regains Nasdaq compliance","bullets":["Dr. Bolno, President and CEO of Wave Life Sciences, appointed to Board and Compensation Committee effective September 22, 2025.","He receives $40,000 annual cash retainer, $5,000 for committee service, and 100,000 stock options vesting over three years.","Christine Akinc resigned from Board and all committees on September 22; departure not due to any disagreement.","Nasdaq notified Invivyd on September 22 that it regained compliance with the $1.00 minimum bid price requirement, closing the matter."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-215541","json":"https://secwatch.observer/filing/0001193125-25-215541.json","markdown":"https://secwatch.observer/filing/0001193125-25-215541.md","text":"https://secwatch.observer/filing/0001193125-25-215541.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832038/000119312525215541/0001193125-25-215541-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832038/000119312525215541/ivvd-20250922.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:48:33.780475+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}